On November 10, GPIXEL rose 7.14% in Regular Trading, trading at HK$46.76, with turnover of HK$452,100.
The latest disclosed catalyst was the company’s announcement that dispatch of the circular related to revisions to the 2026 sales cap under the Changchun Institute of Optics framework agreement, and the renewal of that framework agreement through 2029, would be delayed to on or before November 20 due to additional time needed to finalize certain information.
Previously disclosed details indicated the company proposed raising the 2026 annual sales cap to RMB75 million and setting proposed annual caps of RMB150 million for each year through 2029, reflecting increased demand from research projects for CMOS image sensors and related services. GPIXEL focuses on CMOS image sensor design, development, testing and sales, with products used in industrial imaging, scientific imaging, professional imaging and medical imaging.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments